Gina Dube, PharmD, RPh, CACP

A multidisciplinary team of health care professionals, including pharmacists, can work together to treat patients with the bleeding disorder.

Additional randomized clinical trials are warranted to determine the mechanism between the 2 diseases.

Antiphospholipid Antibody Syndrome may be associated with an increased risk of venous thromboembolism complications in severe cases.

Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.

Significant morbidity and mortality are associated with an aging population due to cardiovascular disease, which is very common in HIV-infected persons.